儿童THRA新变异导致RTHα的功能特征研究
该研究通过全外显子测序在一名发育迟缓、面容异常及生化提示甲状腺激素抵抗的儿童中鉴定出新型THRA杂合移码变异c.1125_1132dup(p.Gly378Alafs*2)。细胞转录实验显示突变受体对T3和TRIAC反应严重受损,且不能被CBP/p300或PGC1α激活,并对野生型THRA产生强显性负效应,破坏DNA结合可消除该干扰。
要点
- 新型THRA移码变异截断配体结合域,导致功能丧失。
- 突变受体对T3和TRIAC反应严重受损,辅助激活因子无法激活。
- 突变受体对野生型THRA有强显性负效应,且依赖DNA结合。
核心结论
- 该新型THRA移码变异通过功能丧失和强显性负效应导致RTHα,扩展了THRA致病变异谱并揭示转录抑制机制。
研究设计与样本
- 病例报告结合全外显子测序鉴定变异,并行细胞水平转录活性及共表达实验。
主要发现
- 鉴定出杂合移码变异c.1125_1132dup(p.Gly378Alafs*2),截断配体结合域。
- 突变受体对三碘甲状腺原氨酸(T3)和TRIAC反应严重受损。
- CBP/p300和PGC1α不能激活突变受体,支持功能丧失。
- 共表达显示突变受体强抑制野生型THRA活性,高浓度T3不能逆转。
- 破坏DNA结合可消除干扰,表明需要DNA占据。
临床怎么用
- 对发育迟缓伴异常甲状腺功能提示RTHα的儿童,可考虑THRA基因检测。
- 功能实验有助于判断THRA变异致病性及显性负效应机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Resistance to thyroid hormone α (RTHα) is a rare disorder caused by pathogenic THRA variants. We investigated the molecular basis of RTHα in a child with developmental delay, dysmorphic features, and a suggestive biochemical profile. METHODS: Whole-exome sequencing identified a de novo THRA variant. Cell-based transcriptional assays assessed thyroid hormone responsiveness, coactivator dependence, and dominant-negative activity. RESULTS: A novel heterozygous frameshift variant, c.1125_1132dup (p.Gly378Alafs*2), truncating the ligand-binding domain, was identified. The mutant receptor showed markedly impaired responses to triiodothyronine (T3) and TRIAC. CBP/p300 and PGC1α failed to activate the variant, supporting loss of function. Co-expression studies demonstrated strong inhibition of wild-type THRA activity that was not rescued by high T3 concentrations, indicating a potent dominant-negative effect. Disruption of DNA binding abolished this interference, showing that DNA occupancy is required. CONCLUSIONS: These findings expand the spectrum of pathogenic THRA variants and provide new insight into transcriptional repression in RTHα.
引用
- Caron V, Bonnycastle K, Rio A, et al. Functional Characterization of a Novel Variant of the Thyroid Hormone Receptor Alpha in a Child with Developmental Delay and Abnormal Thyroid Function. Thyroid. 2026. PMID: 42764528. doi:10.1177/10507256261490862
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。